Watch the video of Dr. Pingpank as he discusses mesothelioma surgery and treatment at UMPC. We meet today with Dr. James Pingpank of the Hillman…
1717 K Street NW, Suite 900
Washington, DC 20006-5349
(877) 363-6376
HELPLINE
The Peer Reviewed Cancer Research Program (PRCRP) is soliciting input regarding the Quality of Life (QoL) and psychosocial aspects of cancer care (diagnosis/treatment/transition to survivorship…
Mesothelioma in and of itself is a misunderstood diagnosis. As a cancer that affects roughly 3,000 Americans per year, it is often mistakenly thought of…
Last week, the Polaris Group announced positive results of its Phase 2/3 clinical trial evaluating the effectiveness of an arginine degrading enzyme agent called ADI-PEG 20.…
The Mesothelioma Applied Research Foundation is proud to announce the recipients of its most recent round of new mesothelioma research funding. Through a rigorous review…
This week, the paper “Medical and surgical care of mesothelioma patients and their relatives carrying germline BAP1 mutations,” by Drs. Michele Carbone, Harvey Pass, and…
Data from a study comparing the efficacy of anetumab ravtansine, a monoclonal antibody conjugate, against vinorelbine showed no improvement in progression-free survival. The results of…
“We are at a point where in the next few years we’re going to have a lot more options for our patients,” said Dr. Hedy…
The field of radiology and imaging has relatively quickly advanced from simple x-rays that allow us to take a non-invasive, albeit limited, peek inside the…
As 2021 concludes and 2022 begins, we bring you mesothelioma treatment news directly from clinicians and researchers. Two newly published articles give us a useful…